Scholarlink

Purpose of Review <p>This review provides comprehensive description of the relationship between cardiac arrhythmias and cancer therapies along with management approaches (medical and interventional).</p> Findings <p>The cancer treatment related cardiotoxicity can cause arrhythmias through direct and indirect mechanisms. The foundation of cardio-oncology involves cardiovascular risk assessment of cancer patients and careful assessment of cardiotoxicity profiles of cancer treatment balancing the risk and benefits of cancer treatments. This is best achieved through a multidisciplinary approach fashion dealing with the theoretical risk of cardiotoxicity and early recognition of actual development of cardiotoxicity throughout cancer journey and beyond. Artificial intelligence is a potential tool that can make delivery of care more effective and efficient for cardio-oncology patients.</p> Summary <p>The management and therapeutic strategies involve careful assessment and close collaboration with the oncology team. The knowledge about prevention and treatment of such cancer treatment induced arrhythmia is important and increasingly being recognized. As more novel treatments emerge, a constant vigilance aimed at identifying and managing cancer treatment associated arrhythmias is essential.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Mechanisms and Management of Arrhythmias in Cancer Patients

  • 期刊论文

  • 发表日期：

    2025年1月29日

查看全文
  • Manyoo A. Agarwal,
  • Aadhavi Sridharan,
  • Hoang Nhat Pham,
  • Lohit Garg,
  • Brijesh Patel,
  • Husam Abdel-Qadir,
  • Rohit Moudgil,
  • Diego Sadler,
  • John Rickard,
  • Michael Fradley

摘要

Purpose of Review

This review provides comprehensive description of the relationship between cardiac arrhythmias and cancer therapies along with management approaches (medical and interventional).

Findings

The cancer treatment related cardiotoxicity can cause arrhythmias through direct and indirect mechanisms. The foundation of cardio-oncology involves cardiovascular risk assessment of cancer patients and careful assessment of cardiotoxicity profiles of cancer treatment balancing the risk and benefits of cancer treatments. This is best achieved through a multidisciplinary approach fashion dealing with the theoretical risk of cardiotoxicity and early recognition of actual development of cardiotoxicity throughout cancer journey and beyond. Artificial intelligence is a potential tool that can make delivery of care more effective and efficient for cardio-oncology patients.

Summary

The management and therapeutic strategies involve careful assessment and close collaboration with the oncology team. The knowledge about prevention and treatment of such cancer treatment induced arrhythmia is important and increasingly being recognized. As more novel treatments emerge, a constant vigilance aimed at identifying and managing cancer treatment associated arrhythmias is essential.